Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A European compassionate use and named patient basis for the treatment of neuroendocrine tumours

Next Previous
Trial Profile

A European compassionate use and named patient basis for the treatment of neuroendocrine tumours

Status: Recruiting
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 24 Nov 2017

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Lutetium-(177Lu)-oxodotreotide (Primary)
  • Indications Neuroendocrine tumours
  • Focus Expanded access; Therapeutic Use

    • Most Recent Events

    • 17 Nov 2017 According to an Advanced Accelerator Applications media release, in an compassionate program 1857 patients were participating from 67 centres in Europe.
    • 31 Aug 2017 According to an Advanced Accelerator Applications media release, an European compassionate program were participating 1800 patients from 62 centres at 31 July 2017.
    • 25 Jul 2017 New trial record
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top